On examination, he was anxious, pulse 92 beats/min, blood pressure 140/90 mmHg, temperature 98 F, respiratory rate was 18 breaths/min, heart sounds were audible and normal without any added sound, lungs were clear in both side.12 lead ECG showed acute ST elevated myocardial infarction in the inferior leads with anterolateral ischemic changes. Cardiac markers revealed CK-MB 65 U/ml and Troponin I was 17 U/ml. Bed side echocardiogram denoted concentric hypertrophy with mild inferior wall hypokinesia with LVEF 60%.
After adequate preparation patient was sent to Cardiac Cath Lab for primary Percutaneous Coronary Intervention (PCI). Coronary angiography revealed there is a 100% stenosis in mid part of the Right Coronary Artery (RCA). Other vessels were normal. A bare metal stent (BMS) was diploid in this lesion following balloon inflation. Revascularization completed with good TIMI 3 flow. The total procedure was uneventful. After procedure patient was shifted to CCU. There was no post procedure complication, patient's chest pain was relieved and he was discharged 3 days after primary PCI.
Discussion:
Now a days Primary Percutaneous Coronary Intervention (PCI) of the infarct artery is the treatment of choice in acute ST elevated myocardial infarction when time-totreatment delays are short and the patient presents to a high-volume, well-equipped center with experienced interventional cardiologists and skilled support staff. It is preferred to fibrinolytic therapy as primary PCI produces higher rates of infarct artery patency, TIMI 3 flow, and access site bleeding and lower rates of recurrent ischemia, reinfarction, emergency repeat revascularization procedures, intracranial hemorrhage (ICH), and death. Early successful PCI also greatly decreases the complications of STEMI that result from longer ischemic times or unsuccessful fibrinolytic therapy, allowing earlier hospital discharge and resumption of daily activities.¹ , ² Primary PCI should be performed in patients with STEMI and ischemic symptoms of less than 12 hours' duration or who have contraindications to fibrinolytic therapy, irrespective of the time delay from FMC or patients with STEMI and cardiogenic shock or acute severe HF, 
